Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

NCT03132493

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Hospital de Elche Elche, Alicante, Spain
  • Hospital Universitario de Vinalopó Elche, Alicante, Spain
  • Hospital General Universitario de Elda Elda, Alicante, Spain
View all 61 locations
View Trial Details
Completed

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

NCT02458651

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China
  • the First Hospital of Jilin University Changchun, China
  • Sichuan Provincial Cancer Hospital Chengdu, China
  • Third Affiliated Hospital of Third Military Medical University Chongqing, China
View Trial Details
Completed

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

NCT01801111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 84 locations
View Trial Details
Completed

Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NCT01836692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Belfast Health & Social Care NHS Trust - Northern Ireland Cancer Centre Belfast, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Leeds Teaching Hospitals NHS Trust - St James's University Hospital Leeds, United Kingdom
View Trial Details
Completed

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

NCT02913443

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • The Ottawa Hospital Cancer Centre; Oncology Ottawa, Ontario, Canada
  • University Health Network; Princess Margaret Hospital; Medical Oncology Dept Toronto, Ontario, Canada
  • Rigshospitalet; Onkologisk Klinik København Ø, Denmark
View Trial Details

Related conditions